Conditions: Graft-versus-host Disease; Acute-graft-versus-host Disease Interventions: Drug: Defibrotide; Drug: Standard of Care Sponsor: Jazz Pharmaceuticals Recruiting
Condition: Steroid-Refractory Acute Graft Versus Host Disease Intervention: Drug: T-Guard Sponsors: Xenikos; National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI); National Marrow Donor Program Recruiting
Conditions: Acute Graft Versus Host Disease; Haploidentical Hematopoietic Stem Cell Transplant Intervention: Drug: ApoGraft Sponsors: Washington University School of Medicine; Cellect Biotechnology Not yet recruiting
Conditions: Acute Graft-versus-Host Disease; Allogeneic Stem Cell Transplant Intervention: Procedure: Blood samples Sponsor: Ohio State University Comprehensive Cancer Center Recruiting
Conditions: Graft-versus-host-disease; GVHD; GVHD, Acute Interventions: Drug: BMS-986004; Drug: Sirolimus; Drug: Tacrolimus Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Bristol-Myers Squibb Recruiting
Condition: Acute-graft-versus-host Disease Intervention: Biological: Fecal microbiota Sponsor: The First Affiliated Hospital of Soochow University Recruiting
Condition: Graft Versus Host Disease Intervention: Biological: Cultured Treg cells Sponsor: H. Lee Moffitt Cancer Center and Research Institute Recruiting
Condition: Graft-versus-host Disease Prevention Interventions: Other: Best Practice; Procedure: Fecal Microbiota Transplantation; Drug: Nystatin; Drug: Piperacillin-Tazobactam Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting
Condition: Acute GVHD Interventions: Drug: Ruxolitinib Oral Tablet; Drug: Methylprednisolone Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Not yet recruiting
Condition: Fecal Microbiota Transplantation in Graft vs. Host Disease Intervention: Biological: Autologous Fecal Microbiota Transplantation Sponsor: Rambam Health Care Campus Not yet recruiting
Conditions: Graft-versus-host Disease; Poor Graft Function; Low Donor T-cell Chimerism Intervention: Biological: Mesenchymal stem cells Sponsors: University of Liege; KU Leuven; Maastricht University Medical Center; Ziekenhuis Netwerk Antwerpen (ZNA); University Hospital, Antwerp; University Hospital, Ghent; AZ-VUB; AZ Sint-Jan AV; Cliniques universitaires Saint-Luc- Université Catholique de Louvain; University Hospital of Mont-Godinne; Jolimont Hospital Haine Saint Paul; Queen Fabiola Children's University Hospital Recruiting
Conditions: Graft Versus Host Disease; Hematopoietic Stem Cell Transplantation; Leukemia Interventions: Drug: CD24Fc; Drug: Methotrexate; Drug: Tacrolimus; Drug: Placebo Sponsors: OncoImmune, Inc.; Ohio State University; University of Michigan Rogel Cancer Center; Indiana University School of Medicine; Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI) Recruiting
Condition: GVHD, Acute Interventions: Biological: Decidua Stroma Cells (DSC); Drug: Best available Treatment (BAT) Sponsors: Mats Remberger; The Swedish Research Council Not yet recruiting
Conditions: Graft Vs Host Disease; Graft-versus-host-disease; Acute-graft-versus-host Disease; Prevention of aGVHD Interventions: Drug: RGI-2001; Drug: Standard of Care Sponsor: Regimmune Corporation Recruiting
Condition: Graft Versus Host Disease (GVHD) Interventions: Biological: Alpha-1 antitrypsin (AAT); Drug: Placebo Sponsors: CSL Behring; Blood and Marrow Transplant Clinical Trials Network; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI); National Cancer Institute (NCI) Not yet recruiting
Conditions: Relapsed Pediatric ALL; Acute Graft-Versus-Host Disease (Gvhd) Grade IV (Diagnosis); Relapsed Pediatric AML Intervention: Procedure: In Vitro T cells depletion using CliniMCAS system Sponsors: Shanghai Children's Medical Center; Nanfang Hospital of Southern Medical University; Children's Hospital Of Soochow University; Chinese University of Hong Kong; Miltenyi Biotec GmbH Not yet recruiting
Conditions: Acute Myeloid Leukemia in Remission; Lymphoma in Remission; Non-progressive Myeloproliferative Syndrome; Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts; Acute Leukemia Biphenotypic in Remission; Acute Lymphoblastic Leukemia Intervention: Diagnostic Test: Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test Sponsors: Assistance Publique - Hôpitaux de Paris; SATT; SNC Graft Versus Host Disease; Imagine Institute; AXONAL-BIOSTATEM; CERBA laboratory Not yet recruiting
Condition: Graft Versus Host Disease in GI Tract Intervention: Biological: Fecal microbiota transplantation Sponsor: Medical University of Graz Recruiting
Condition: Hematopoietic and Lymphoid Cell Neoplasm Intervention: Biological: fecal microbiome transplantation Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting
Conditions: Acute Leukemia; Chronic Myelogenous Leukemia (CML); Myelodysplasia; Lymphoma Interventions: Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate; Drug: Tacrolimus; Drug: Methotrexate; Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Mycophenolate Mofetil/Post-Transplant Cyclophosphamide; Drug: Mycophenolate Mofetil; Drug: Cyclophosphamide Sponsors: Medical College of Wisconsin; National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI); National Marrow Donor Program Recruiting